InMode (INMD) EPS (Basic) Growth (1y) (2019 - 2026)
InMode (INMD) EPS (Basic) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 13.85% |
| 10 | InMode | 912.51 Mn | 497.35 Mn | 71.52 Mn | -99.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.11% |
| Dec 31, 2025 | 337.76% |
| Sep 30, 2025 | -49.25% |
| Jun 30, 2025 | 48.89% |
| Mar 31, 2025 | -5.58% |
| Dec 31, 2024 | -129.66% |
| Sep 30, 2024 | 19.12% |
| Jun 30, 2024 | -62.00% |
| Mar 31, 2024 | -42.45% |
| Dec 31, 2023 | 70.63% |
| Sep 30, 2023 | -6.03% |
| Jun 30, 2023 | 39.48% |
| Mar 31, 2023 | 30.48% |
| Dec 31, 2022 | -29.33% |
| Sep 30, 2022 | 9.38% |
| Jun 30, 2022 | 6.96% |
| Mar 31, 2022 | 8.95% |
| Dec 31, 2021 | 29.33% |
| Sep 30, 2021 | 60.92% |
| Jun 30, 2021 | 308.16% |